Research ArticleArticle
Open Access
COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN)
Baptiste Chevet, Gabriel Figueroa-Parra, Jeffrey X. Yang, Cassondra A. Hulshizer, Tina M. Gunderson, Stephanie Q. Duong, Michael S. Putman, Kamil E. Barbour, Cynthia S. Crowson and Alí Duarte-García
The Journal of Rheumatology July 2022, jrheum.220220; DOI: https://doi.org/10.3899/jrheum.220220
Baptiste Chevet
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Gabriel Figueroa-Parra
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Jeffrey X. Yang
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Cassondra A. Hulshizer
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Tina M. Gunderson
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Stephanie Q. Duong
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Michael S. Putman
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Kamil E. Barbour
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Cynthia S. Crowson
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Alí Duarte-García
Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Article Information
jrheum.220220
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online July 1, 2022.
Article Versions
- You are currently viewing a Latest version of this article (July 1, 2022 - 04:00).
- latest version (September 15, 2022 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2022 The Journal of Rheumatology
Author Information
- Baptiste Chevet,
- Gabriel Figueroa-Parra,
- Jeffrey X. Yang,
- Cassondra A. Hulshizer,
- Tina M. Gunderson,
- Stephanie Q. Duong,
- Michael S. Putman,
- Kamil E. Barbour,
- Cynthia S. Crowson and
- Alí Duarte-García
- Funding Information: The Lupus Midwest Network (LUMEN) project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) under Grant number U01 DP006491 as part of a financial assistance award totaling $1,750,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government. The Rochester Epidemiology Project was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676, and Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
CDC Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.
B. Chevet, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. Division of Rheumatology, Brest Teaching Hospital, LBAI, UMR1227, Univ Brest, Inserm, CHU de Brest, Brest, France. G. Figueroa-Parra, MD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA. J.X. Yang, MD, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. C.A. Hulshizer, BA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. T.M. Gunderson, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. S.Q. Duong, MS, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. M.S. Putman, MD, MSci, Division of Rheumatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. K.E. Barbour, PhD, MPH, MS, Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. C.S. Crowson, PhD, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA. Alí Duarte- García, MD, MSc, Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.
Corresponding author: Alí Duarte-García MD, MSc, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Email: duarte.ali@mayo.edu
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN)
Baptiste Chevet, Gabriel Figueroa-Parra, Jeffrey X. Yang, Cassondra A. Hulshizer, Tina M. Gunderson, Stephanie Q. Duong, Michael S. Putman, Kamil E. Barbour, Cynthia S. Crowson, Alí Duarte-García
The Journal of Rheumatology Jul 2022, jrheum.220220; DOI: 10.3899/jrheum.220220
COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN)
Baptiste Chevet, Gabriel Figueroa-Parra, Jeffrey X. Yang, Cassondra A. Hulshizer, Tina M. Gunderson, Stephanie Q. Duong, Michael S. Putman, Kamil E. Barbour, Cynthia S. Crowson, Alí Duarte-García
The Journal of Rheumatology Jul 2022, jrheum.220220; DOI: 10.3899/jrheum.220220